• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性醛固酮增多症诊断中的确证试验。

Confirmatory tests in the diagnosis of primary aldosteronism.

机构信息

Division of Internal Medicine, Department of Medicine and Experimental Oncology, University of Torino, Torino, Italy.

出版信息

Horm Metab Res. 2010 Jun;42(6):406-10. doi: 10.1055/s-0029-1246186. Epub 2010 Jan 29.

DOI:10.1055/s-0029-1246186
PMID:20119882
Abstract

Primary aldosteronism is the most common form of secondary hypertension and patients with hyperaldosteronism are more prone to premature cardiovascular complications compared to essential hypertensives. The diagnostic flow-chart for the diagnosis of PA is performed in three steps: a) screening; b) confirmation; and c) subtype differentiation. Instead of proceeding directly to subtype classification, the recently published Endocrine Society Guidelines recommend that patients with a positive ARR should undergo a confirmatory test, in order to definitively confirm or exclude the diagnosis of PA. The Guidelines recognize four testing procedures: oral sodium loading, saline infusion, fludrocortisone suppression, and captopril challenge. Herein we discuss the diagnostic protocols for these confirmatory tests and highlight both the advantages and contraindications and we discuss studies in which these confirmatory tests have been compared.

摘要

原发性醛固酮增多症是继发性高血压最常见的形式,与原发性高血压患者相比,醛固酮增多症患者更容易发生心血管并发症。醛固酮增多症的诊断流程图分为三个步骤:a)筛查;b)确诊;和 c)亚型鉴别。最近发表的《内分泌学会指南》建议,ARR 阳性的患者应进行确诊试验,以明确诊断或排除醛固酮增多症,而不是直接进行亚型分类。该指南认可了四种检测程序:口服钠负荷、盐水输注、氟氢可的松抑制和卡托普利挑战。本文讨论了这些确诊试验的诊断方案,重点介绍了它们的优势和禁忌证,并讨论了比较这些确诊试验的研究。

相似文献

1
Confirmatory tests in the diagnosis of primary aldosteronism.原发性醛固酮增多症诊断中的确证试验。
Horm Metab Res. 2010 Jun;42(6):406-10. doi: 10.1055/s-0029-1246186. Epub 2010 Jan 29.
2
Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?血浆醛固酮与肾素比值可预测原发性醛固酮增多症的治疗反应:是否需要扩容?
Blood Press. 2005;14(4):245-50. doi: 10.1080/08037050510034329.
3
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis.原发性醛固酮增多症,低肾素性高血压的主要形式:从筛查到诊断
Trends Endocrinol Metab. 2008 Apr;19(3):104-8. doi: 10.1016/j.tem.2008.01.005. Epub 2008 Mar 4.
4
Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism.盐水输注试验与氟氢可的松抑制试验诊断原发性醛固酮增多症的比较。
Horm Metab Res. 2012 Jun;44(7):527-32. doi: 10.1055/s-0032-1314786. Epub 2012 Jun 11.
5
Screening for primary aldosteronism.原发性醛固酮增多症的筛查
Best Pract Res Clin Endocrinol Metab. 2006 Sep;20(3):369-84. doi: 10.1016/j.beem.2006.07.007.
6
Aldosterone to renin ratio--a reliable screening tool for primary aldosteronism?醛固酮与肾素比值——原发性醛固酮增多症的可靠筛查工具?
Horm Metab Res. 2010 Jun;42(6):382-91. doi: 10.1055/s-0030-1248326. Epub 2010 Mar 11.
7
[The aldosterone to Renin ratio in secondary hypertension].[继发性高血压中的醛固酮与肾素比值]
Herz. 2003 Dec;28(8):686-91. doi: 10.1007/s00059-003-2507-7.
8
Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.原发性醛固酮增多症诊断中筛查和确诊试验的分析:需要标准化方案。
J Hypertens. 2006 Apr;24(4):737-45. doi: 10.1097/01.hjh.0000217857.20241.0f.
9
Primary aldosteronism: the role of confirmatory tests.原发性醛固酮增多症:确证试验的作用。
Horm Metab Res. 2012 Mar;44(3):177-80. doi: 10.1055/s-0032-1304661. Epub 2012 Mar 6.
10
Primary aldosteronism: renaissance of a syndrome.原发性醛固酮增多症:一种综合征的复兴
Clin Endocrinol (Oxf). 2007 May;66(5):607-18. doi: 10.1111/j.1365-2265.2007.02775.x.

引用本文的文献

1
Comparison of different criteria of captopril challenge test for the diagnosis of primary aldosteronism.卡托普利激发试验不同诊断标准对原发性醛固酮增多症诊断的比较
Endocrine. 2025 Jul 5. doi: 10.1007/s12020-025-04326-4.
2
Diabetes Mellitus Secondary to Endocrine Diseases: An Update of Diagnostic and Treatment Particularities.内分泌疾病继发糖尿病:诊断和治疗特点的更新。
Int J Mol Sci. 2023 Aug 11;24(16):12676. doi: 10.3390/ijms241612676.
3
Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS.用盐水输注试验和 LC-MS/MS 对原发性醛固酮增多症进行确证性检测。
Eur J Endocrinol. 2021 Jan;184(1):167-178. doi: 10.1530/EJE-20-0073.
4
The Prevalence of Primary Aldosteronism and Evolving Approaches for Treatment.原发性醛固酮增多症的患病率及不断发展的治疗方法。
Curr Opin Endocr Metab Res. 2019 Oct;8:30-39. doi: 10.1016/j.coemr.2019.07.001. Epub 2019 Jul 9.
5
The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.原发性醛固酮增多症的扩展谱:对诊断、发病机制和治疗的影响。
Endocr Rev. 2018 Dec 1;39(6):1057-1088. doi: 10.1210/er.2018-00139.
6
Hyperaldosteronism: How to Discriminate Among Different Disease Forms?原发性醛固酮增多症:如何区分不同的疾病形式?
High Blood Press Cardiovasc Prev. 2016 Sep;23(3):203-8. doi: 10.1007/s40292-016-0151-6. Epub 2016 May 2.
7
Hyperaldosteronism: Screening and Diagnostic Tests.醛固酮增多症:筛查与诊断测试
High Blood Press Cardiovasc Prev. 2016 Jun;23(2):69-72. doi: 10.1007/s40292-016-0136-5. Epub 2016 Mar 14.
8
Shortened saline infusion test for subtype prediction in primary aldosteronism.用于原发性醛固酮增多症亚型预测的简化盐水输注试验
Endocrine. 2015 Dec;50(3):802-6. doi: 10.1007/s12020-015-0615-9. Epub 2015 May 1.
9
Issues in the Diagnosis and Treatment of Primary Aldosteronism.原发性醛固酮增多症的诊断与治疗问题
High Blood Press Cardiovasc Prev. 2016 Jun;23(2):73-82. doi: 10.1007/s40292-015-0084-5. Epub 2015 Apr 9.
10
Management of hypertension in primary aldosteronism.原发性醛固酮增多症的高血压管理
World J Cardiol. 2014 May 26;6(5):227-33. doi: 10.4330/wjc.v6.i5.227.